BIOMEDICAL RESEARCH AND REVIEWS

ISSN 2631-3944

Perfusion and Oxygenation Changes after Isolated Limb Perfusion with TNF - alpha in Lower Limb Sarcoma: A Case Report

Katerina Nikiforaki1,2*, Georgios C. Manikis1,2, Maria Venianaki1,3, Eleftherios Kontopodis1,2, Eleni Lagoudaki4, Thomas G. Maris2, Kostas Marias1,5, Eelco de Bree6, Apostolos Karantanas1,2

1 Computational BioMedicine Laboratory (CBML), Foundation for Research & Technology, Heraklion, Crete, Greece
2 Department of Radiology, School of Medicine,, University of Crete, Greece
3 Image Analysis Research Unit, IMT School for Advanced Studies Lucca, Italy
4 Department of Pathology, , University Hospital of Crete, Greece
5 Technological Educational Institute of Crete, Department of Informatics Engineering, Greece
6 Department of Surgical Oncology, School of Medicine, University of Crete, Greece

CitationCitation COPIED

Nikiforaki K, Manikis GC, Venianaki M, Lagoudaki E, Maris TG, et al. Perfusion and oxygenation changes after isolated limb perfusion with TNF-? in lower limb sarcoma: a case report. Biomed Res Rev. 2018Mar; 1(1):101

Abstract

Tumor necrosis factor alpha (TNF-α) is known to cause selective destruction of tumor neovascularisation. Perfusion changes in tumor microenvironment were studied in a young patient with a high-grade myxoid liposarcoma after isolated limb perfusion with TNF-α and melphalan, using advanced MR imaging. Quantitative and semi-quantitative evaluation of perfusion metrics included ktrans/f/T2* shift and automatic extraction of enhancement patterns. Strong agreement between different methods is consistent with response to therapy, specifically reduced perfusion (mean ktrans shifted from 0.424 to 0.099 mL/g/min, mean f from 33.5 to 7.3%), reduced hypoxia indication (mean T2* increased from 72 to 82 ms) and prevalence of necrotic areas.

Keywords

Tumor Necrosis Factor-α; MR imaging/diagnosis; Pattern Recognition; Tumor hypoxia; Cancer imagenomics; Liposarcoma/treatment response

Abbreviations

(TNF-α) : Tumor Necrosis Factor Alpha

ILP : Isolated limb perfusion

DCE : Dynamic Contrast Enhanced

DWI : Diffusion Weighted Imaging

IVIM : Intravoxel Incoherent Motion

T2*r : T2* Relaxometry

BOLD : Blood Oxygen Level-Dependent

PK : Pharmacokinetic

ktrans : Transendothelial permeability

dHb : Deoxyhemoglobin

IMVD : Intratumoral Microvessel Density

FISH : Fluorescence In situ Hybridization

PR : Pattern Recognition

Introduction

Isolated limb perfusion (ILP) has been used for locally advanced extremity soft tissue sarcoma in order to avoid amputation when wide excision of the tumor is not feasible [1]. Subsequently (marginal) excision of the tumor is performed 6 to 8 weeks after this regional chemotherapy treatment. A drug combination of tumor necrosis factor alpha (TNF-α) and melphalan is usually used. TNF-α is multifunctional cytokine that plays a major role in innate and acquired immunity while its binding to certain receptors leads to hemodynamic and antitumor effects [2]. The administration of TNF-α during ILP inhibits devastating systemic hemodynamic effects and shows a strong synergistic antitumor action with chemotherapeutic agents in sarcoma patients [3]. In the setting of ILP TNF-α has two distinct antitumor properties that may be related to each other: increased uptake of chemotherapeutic drugs such as melphalan into the tumor and selective destruction of tumor neovascularization [2]. In experimental studies TNF-α has led to increased vessel permeability and decreased interstitial pressure as immediate effects after administration [4,5]. These early antivascular effects lead to an up to 6-fold–increased uptake of melphalan into the tumor [6]. Late antivascular effects such as tumor vessel disintegration and endothelial apoptosis which may ultimately result in tumor necrosis are best demonstrated in imaging obtained before and after ILP with TNF-α [7].

The evaluation of tumor response to therapy by non-invasively assessing blood supply and oxygen level has been a long-standing endeavor in MR imaging (MRI). To this end clinically relevant perfusion biomarkers extracted from Dynamic Contrast Enhanced (DCE) Diffusion Weighted Imaging (DWI) and T2* relaxometry (T2*r) are indicative of various pathophysiological properties of tissue vascularity [8,9]. 

Specifically DCE MRI evaluates the temporal pattern of enhancement from multiple dynamic acquisitions of high temporal resolution. A recent semi-quantitative analysis framework relies on a pattern recognition (PR) method namely BU-NMF [10] which extracts automatically the principal enhancement patterns that describe DCE data and assigns a certain enhancement profile to each image pixel. These patterns can be labeled as necrotic hypoxic and well-perfused and were associated with the three most common enhancement patterns found in tumors [11] which are described by steady and subtle enhancement (Type 1) by delayed enhancement and some wash-out (Type 2) and by rapid enhancement and wash-out (Type 3). Additionally quantitative analysis based on pharmacokinetic (PK) models [12] provides estimates of transfer rates of the contrast agent from plasma to tissue (transendothelial permeability-ktrans). 

However the DCE is not the only MRI method providing metrics indicative of vascularity. Intravoxel incoherent motion (IVIM) model of DWI may separate microcirculatory from thermal diffusion effects and can be used to study microcirculatory blood flow properties by estimating the microperfusion fraction f [13] i.e. the fraction of DWI signal arising from incoherent blood flow motion.

A third MRI method related to blood supply is the Blood Oxygen Level-Dependent (BOLD) which indirectly measures the total amount of deoxyhemoglobin (dHb) levels in a voxel. Conceptually the paramagnetic nature of deoxyhemoglobin as opposed to oxyhemoglobin accelerates T2* relaxation shortening thus T2* constants of tissue around the blood vessels. Importantly dHb levels depend on a number of concurrent phenomena such as blood flow blood oxygenation vasculature hemoglobin levels etc. [14] Because of the complex interplay between blood supply and oxygen extraction changes in oxygen delivery (blood flow) are not directly related to changes of oxygen consumption and dHb changes do not always match the expected action of the vascular stimulus. T2*r can provide information regarding tumor microenvironment as it reflects tissue oxygen bioavailability. Larger T2* tissue constants as a result of lower dHb concentration may indicate lower blood flow lower tissue oxygenation deficient vascular network etc. and is consistent with tumor response to therapy [9].

Although based on different grounds all three techniques have been widely used for tumor characterization. To our knowledge MRI analysis of TNF induced perfusion have only been studied in animals [15] and have shown changes in endothelial permeability after therapy as measured by perfusion biomarkers. This case study shows the vascularity changes in a lower limb sarcoma after ILP with TNF-α based on quantitative and semi-quantitative MRI methods. 

Patient History

A 40-year-old patient was referred for MRI scan of the left foot. Six months prior to imaging he had suffered from local pain during walking and had noticed a gradually growing tumor at its dorsolateral site. X-Ray showed a soft tissue mass between the 4th and the 5th metatarsal bones of the right left foot with bone remodeling and deformity (Figure 1). The mass was painless and slowly growing. Advanced MRI was performed before any biopsy. Since an ultrasoundguided core needle biopsy was inconclusive an open biopsy from the dorsal site of the soft tissue tumor was performed. At histological examination of the macroscopically grey to white color tissue with a myxoid-fleshy consistency the lesion presented a subtle multinodular conformation exhibited areas of variable cellular density with enhancement of cellularity at the periphery and was composed of bland fusiform or round cells suspended individually in a myxoid matrix with a prominent network of arborizing thin-walled capillary vessels often in a “chicken-footprint” configuration (Figure 2). Pools of extracellular mucin with cellular condensation at the rim were focally present. Mitotic figures were absent and lipoblasts were not identified. Immunohistochemical staining was positive for Vimentin only. Based on rearrangement of DDIT-3 gene which was detected using Fluorescence in Situ Hybridization (FISH)the histopathological diagnosis of high grade myxoid liposarcoma was made.

Figure 1: Magnified oblique view of the left foot, shows a soft tissue mass (asterisk) with displacement and remodelling of the 4th metatarsal (arrow)